Stada Arzneimittel AG - Company Profile
Powered by 
All the data and insights you need on Stada Arzneimittel AG in one report.
$295
- Save hours of research time and resources with
our up-to-date Stada Arzneimittel AG Strategy Report
- Understand Stada Arzneimittel AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Stada Arzneimittel AG Catalyst Calendar
Proactively evaluate Stada Arzneimittel AG’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Stada Arzneimittel AG Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 30 Jun 2021 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 17 Jun 2021 | Phase III Trial Completion | AIM Foundation; Barts Charity; Barts Health NHS Trust; Cytoplan Ltd; DSM Nutritional Products Ltd; Fischer Family Trust; Hyphens Pharma Pte Ltd; NIHR Clinical Research Network; Pharma Nord (UK) Ltd; Queen Mary University of London; Synergy Biologics Ltd; Thornton & Ross Ltd | - | cholecalciferol | Infectious Disease; Respiratory | Coronavirus Disease 2019 (COVID-19); Respiratory Tract Infections | Clinical Trial Registry |
| 11 May 2021 | Phase III Trial Completion | Stada Arzneimittel AG; Syneos Health Inc; Xbrane Biopharma AB | SYNH; XBRANE | ranibizumab biosimilar | Metabolic Disorders; Ophthalmology | Age Related Macular Degeneration; Diabetic Macular Edema; Diabetic Retinopathy; Macular Degeneration; Wet (Neovascular / Exudative) Macular Degeneration | Clinical Trial Registry |
| 31 Dec 2020 | Phase II Trial Completion | Nizhpharm | - | meloxicam; thiocolchicoside | Central Nervous System | Low Back Pain; Neck Pain (Cervicalgia); Pain | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer